According to news reports, The Very Group, is looking to float after calling off their plan for a £4bn IPO last year due to a volatile market. The ecommerce group is owned by the Barclays family. According to the Sunday Times, the retailer has offered incentives to senior leaders at the firm for pulling off a flotation, which the Barclays family now hope to get underway in mid-2023.
Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business networking platform), that is developing the Blossom Database pursuant to a third party licensing arrangement. The Company also has an investment of 426,000 common shares in Awakn, a Canadian NEO Exchange listed psychedelics research and clinical group, with operations in the UK and Europe. Psych is developing the Blossom Database pursuant to a third-party licensing arrangement, and Psych will work to develop an artificial intelligence platform that will provide biotech companies advanced clinical data that will be able to fast-track drug development and loop back the real-world data, in a centralised database, to provide feedback on molecules and associated therapy programmes. Due Date 9th June 2022.
Altona Rare Earths, the AQSE listed mining exploration Company focused on the evaluation, acquisition and development of Rare Earth Elements mining projects in Africa, intends to join the Main Market. Admission to trading of the Company’s Ordinary Shares on the AQSE Growth Market will be cancelled simultaneously with Admission. It is also proposed that on Admission, the Company will change its EPIC from AQSE:ANR to REE. The Company also seeks to raise funds to finance its current and future rare earths mining projects in Southern and Eastern Africa. Due June 2022.
4D Pharma 33.77p £60.9m (DDDD.L)
A pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced the presentation of a trial in progress poster from the Phase II clinical trial of MRx0518 in combination with BAVENCIO® (avelumab), a PD-L1 blocking antibody, as a first-line maintenance therapy for patients with unresectable locally advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-containing chemotherapy, at the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, IL. The study is being conducted in collaboration with Merck KGaA, Darmstadt, Germany and Pfizer Inc.
Aura Energy 11.25p £56.8m (AURA.L)
Aura Energy Limited (ASX:AEE, AIM:AURA), a company focused on the development of the 85% owned Tiris Uranium Project in Mauritania, announces that a diamond drill rig has been mobilised to Tiris from Nouakchott, to commence the 10,000 metre infill drilling program, with results expected in Q4 FY2022. The diamond drilling will generate large diameter (PQ) core in approximately 60 holes to validate the downhole radiometric logging results that the resource estimate will be based on, and will provide density data throughout the deposit. As announced on 20 January, Aura’s 2022 resource upgrade program will include further drilling, seeking to upgrade more of the Company’s 56 Mlb resource from Inferred to Measured and Indicated, and to identify further exploration targets within the tenure. The program is designed to expand what is already one of the lowest capex and lowest operating cost uranium projects in the world.
Big Technologies 286.5p £830.7m (BIG.L)
Big Technologies plc, the UK-based, remote people monitoring technology company, will hold its first AGM in London today. At the meeting, Simon Collins, Chairman, will make the following statement for the four months ended April 2022.“Following our initial public offering in July 2021, I am pleased to report that the team at Big Technologies has adjusted well to life as a listed business and we are confident in the future prospects for the Group. Our customers, suppliers, employees and shareholders have all benefitted from our listing, which brings increased disclosure, scale, financial strength and flexibility.” “In the four months ending April 2022, we have recorded unaudited consolidated revenue of £13.9m, an increase of 18% versus the same period in 2021. Monthly Recurring Revenue in April 2022 was £3.9m and net cash as at 30 April 2022 increased to £52.6m. These positive trends lead the Board to remain confident in the Group’s ability to deliver results at least in line with current market expectations”. “Our business has a clear strategy and strong values which underpin everything that we do. Our systems are trusted the world over to make a tangible difference to people’s lives and we look forward to the next few years with confidence.”
Bushveld Minerals 9.25p £117.1m (BMN.L)
The AIM-listed, integrated primary vanadium producer which owns high-grade vanadium assets in South Africa, announces the appointment of David Noko as an independent non-executive director to the Board of Directors, concurrent with this appointment, the Company also announces the retirement of Anthony Viljoen from the Board. David has years of experience both as an executive and more recently as board member on several prominent companies, including, Royal Bafokeng Platinum Limited, Harmony Gold Mining Company Limited, AstraPak Pty Ltd and Platistone Holdings (Pty) Ltd. He is currently a Non-Executive Director at inter alia African Rainbow Minerals and Tongaat Hulett, as well as being a Lead Advisor at his consultancy company, ESG Advisory Ltd. He is also the Chairman of the Council of the University of the Free State. David’s career included senior roles at General Electric Company, Pepsi Cola International, South African Breweries (Pty) Ltd, De Beers Group and most recently held the position of Executive Vice President at AngloGold Ashanti.
Gemfields 16.15p £118.1m (GEM.L)
Gemfields announces the results of a record-breaking emerald auction comprising a series of five sequential mini-auctions held during the period 9 – 26 May 2022. The auction contained a selection of grades that are typically offered at Kagem Mining Ltd’s (Kagem) auctions of higher quality emeralds as well as one special piece. The auction lots were made available for in-person and private viewings by customers in Bangkok, Thailand. Following the viewings, the bidding took place via an online auction platform which permitted customers from multiple jurisdictions to participate in a sealed-bid process. Highlights include: Total revenues of USD $43.3m, an all-time record for Kagem auctions; All 38 lots offered were sold (100%); Average price of USD 155.90 per carat, an all-time record for Kagem auctions; 100% of the carats offered were sold; The 41 auctions of Kagem gemstones held since July 2009 have generated USD 835.3m in total revenues.
Hummingbird Resources 13.25p £52.2m (HUM.L)
Announces its audited financial results for the year ended 31 December 2021. Financial results: Sales of US$156.6m (2020: US$181.7m) were generated from 87,553 oz of gold sold in 2021 at an average price of US$1,788/oz (2020: 104,174 oz sold at an average price of $1,745/oz), with additional US$6.2m (2020: US$3.4m) revenue generated from sale of SMO gold. EBITDA of US$28.2m (2020: US$75.2m). Adjusted EBITDA of US$18.6m (2020: US$62.3m). Diluted loss per share of US$ 2.78 cents (2020: earnings per share of US$ 5.02 cents). Total bank debt of US$61.8m with US$13.2m capital repaid in the year. Net debt of US$21.0m (2020: net cash $1.5m). Operational Results: 87,558 oz of gold poured in 2021 (2020 : 101,069 oz). All in Sustaining Cost of US$ 1,536 /oz in 2021 (2020 : US$1,147/oz). Total Recordable Injury Frequency Rate of 0.59 (2020: 0.82). Company Reserves increased to c.1.12m ounces in 2021, a 438,600 oz increase to the previous Company reserve statement in October 2019 of 672,000 oz. Completion of c.68.000 metre drilling programme in 2021 at both Yanfolila, Mali and Kouroussa, Guinea.
In The Style 87.5p £45.9m (ITS.L)
In The Style is proud to announce that it has raised half a million pounds in aid of The Bowelbabe Fund for Cancer Research UK. The funds have been raised through the sale of the Dame Deborah James ‘Rebellious Hope’ t-shirt, the first item to be unveiled to customers from In The Style’s Dame Deborah James collection, as well as from the sale of products within the full collection during the evening of its launch on Thursday. The collection comprises 18 products and is available in sizes 6-28. It includes dresses, skirts, blazers, shirts and blouses, t-shirts and hair accessories, with each and every piece perfectly encapsulating the British summertime and activities that Dame Deborah loves. In The Style would like to extend its thanks to logistics partners Evri and Mandarin Global Logistics for their support with reduction on delivery costs, to increase the amount paid to The Bowelbabe Fund.
Kibo Energy* 0.165p £5m (KIBO.L)
The renewable energy focused development company, announces the termination of its intended acquisition of the Victoria Falls Solar Park project in Zimbabwe from Broomfield International Limited. Kibo has concluded its due diligence investigation on the Project, the findings of which were not completely to the satisfaction of Kibo, with certain aspects of the Project requiring some further development work over a short period of time and in other instances, Broomfield not being able to provide certain material information with regards to the Project to Kibo’s satisfaction. In light of the discussions relating to the Transaction being terminated, Kibo’s restoration to trading, and commencement of dealings, on AIM and the AltX of the JSE of the Company’s existing Ordinary Shares will become effective at 7.30 a.m. and 9.00am today respectively. Kibo will now focus its attention and efforts on its existing and new sustainable and renewable energy projects, most notably its Waste-to-Energy project in South Africa which is progressing to financial close, and its new Long Duration Energy Storage solutions project to deploy 1 Gigawatt over the course of the 5-year term in partnership with CellCube. Furthermore, Kibo is in the process of examining the conversion of its existing energy projects in Tanzania, Botswana and Mozambique to clean / renewable energy projects.
Phoenix Global Resources 3.97p £110.6m (PGR.L)
The upstream oil and gas company announces its audited final results for the year ended 31 December 2021. Highlights include: Revenue of US$78.4m (2020: US$54m). Adjusted EBITDA US$13.1m (2020: Adjusted EBITDA loss of US$7.2m). Cash generated from operations US$49.6m (2020: cash used in operations US$6.3m). Operating loss of US$58.7m (2020: loss of US$219.7m). Average daily sales in 2021 of 4,425 beopd (2020: 3,776 boepd). 2P reserves at 54.0MMboe (2020: 18.8MMboe). Chairman, Sir Michael Rake commented: “Argentina continues to experience high inflation and a continuous devaluation of the Peso. The country is in its fourth straight year of recession. Whilst agreement has been reached between the Argentine government and the IMF to restructure the country’s US$45bn of debt, the underlying economic indicators are not encouraging. Notwithstanding, the current administration continues its intent to provide economic and regulatory support to four key sectors of the economy: agriculture; oil and gas; mining; and intellectual services.”
XL Media 30p £78.1m (XLM.L)
A leading global digital performance publisher, announces the appointment of David King as Chief Executive Officer and as a member of the Board of Directors. He is expected to join the Group on 1 July 2022. Stuart Simms, the Company’s existing CEO, announced his intention to step down on April 4 2022 and will leave the Company following a period supporting an orderly handover with David. David joins the Company having held a number of senior Executive roles in companies across the media sector, most recently as CEO at JPIMedia Group, where he led the business through a period of considerable change. This included leading the digital acceleration programme, incorporating a data led strategy to drive audience growth and build new digital revenue streams. David also oversaw an ongoing rationalisation programme, growth of ‘the i’ newspaper and the sale of the group in three stages. David brings extensive leadership and financial expertise. Before entering local media, David was appointed Time Out’s first CEO and before that was CFO of BBC Worldwide for nine years. In his early career David spent six years as a Management Consultant at PwC, working with a number of blue-chip clients. He is a qualified Chartered Accountant.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
